US. Serial No. 17/721,.831
`Response to Restriction Requirement mailed July 19, 2023
`
`Attorney Docket No. 46682-7013 19
`
`
`
`This listing of claims replaces all prior versions and listing of claims in the above-
`
`referenced patent application. The following amendments do not constitute an admission
`
`regarding the patentability of the amended subject matter and should not be so construed.
`
`Amendments to the claims were made for purposes of more clearly stating the claimed subject
`
`matter and do not add new matter or alter the scope of the claims. Deletions are denoted by
`
`[strikethrough] and additions are denoted by underline.
`
`Listing of the Claims
`
`31.-48. (Canceled)
`
`49. (Withdrawn) An ophthalmic composition, comprising about 0.001 % w/vto about 0.05 %
`
`wiv atropine, sodium chloride, glycerin; chitosan; povidone; and water, at a pH of from
`
`about 3.8 to about 7.5.
`
`50. (Withdrawn) The ophthalmic composition of claim 49, comprising about 0.025 % wiv
`
`atropine.
`
`51. (Withdrawn) The ophthalmic composition of clairn 49, comprising about 0.01 % wiv
`
`atropine,
`
`52. (Withdrawn) The ophthalmic composition of claim 49, comprising about 0.05 % w/y
`
`atropine.
`
`33. (Withdrawn) The ophthalmic composition of claim 49, further comprising edetate
`
`disodium.
`
`54. (Withdrawn) The ophthalmic composition of claim 49, wherein the ophthalmic
`
`composition has a pH of about 5.5.
`
`ira) aH . (Withdrawn) The ophthalmic composition of claim 49, wherein the composition has a
`
`dose-to-dose ophthalmic concentration variation of less than 40%.
`
`Cas oN . Withdrawn) The ophthalmic composition of claim 49, wherein the ophthalmic
`
`composition comprises at least about 80%of the atropine based on initial concentration
`
`after extended period of time under storage condition.
`
`

`

`US. Serial No. 17/721,.831
`Response to Restriction Requirement mailed July 19, 2023
`
`Attorney Docket No. 46682-7013 19
`
`. (Withdrawn) The ophthalmic composition of claim 56, wherein the ophthalmic
`
`composition further has a potency of one ofat least 80%after extended period of time
`
`under storage condition.
`
`. Withdrawn) The ophthalmic composition of claim 56, wherein the storage condition has
`
`a storage temperature of from about 2°C to about 10°C or from about 16°C to about 26°C.
`
`.
`o
`a
`-
`oO
`oO
`_ {Previously Presented) A method oftreating myopia, comprisine administering an
`
`ophthalrnic composition to a subject in need thereof, wherein the ophthalmic composition
`
`comprises: about 0.001 % w/v to about 0.05 % w/v atropine; sodium chloride; glycerin:
`
`chitosan; povidone; and water, at a pH of from about 3.8 to about 7.5.
`
`60.
`
`(Previously Presented) The method of claim 59, comprising about 0.025 % w/vatropine.
`
`6l.
`
`‘Previously Presented) The method of claim 59, comprising about 0.01 %w/vatropine.
`.
`ow
`a
`2
`f
`
`2. (Previously Presented) The method of claim 59, comprising about 0.05 %w/v atropine.
`ae
`a
`
`. Previously Presented) The method of claim 59, further comprising edetate disodium.
`
`64.
`
`(Previously Presented) The method of claim 59, wherein the ophthalmic composition has
`
`a pHof about 5.5.
`
`65.
`
`(Previously Presented) The method of claim 59, wherein the cornpasition has a dose-to-
`
`dose ophthalmic concentration variation of less than 40%.
`
`66.
`
`(Previously Presented) The method of claim 59, wherein the ophthalmic composition
`
`comprises at least about 80°of the atropine based on inthal concentration after extended
`
`period of time under storage condition.
`
`. (Previously Presented) The method of claim 66, wherein the ophthalmic composition
`
`further bas a potency of one of: at least 80%after extended period of time under storage
`
`condition.
`
`O&.
`
`(Previously Presented) The method of claim 66, wherein the storage condition has a
`
`storage temperature of from about 2°C to about 10°C or from about 16°C to about 26°C.
`
`

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket